Corvus Capital Ltd. 13D and 13G filings for Conduit Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-09-19 4:59 pm Sale |
2024-03-26 | 13D | Conduit Pharmaceuticals Inc. CDT |
Corvus Capital Ltd. | 302,927 31.560% |
-153,011![]() (-33.56%) |
Filing |
2023-09-29 4:30 pm Purchase |
2023-09-22 | 13D | Conduit Pharmaceuticals Inc. CDT |
Corvus Capital Ltd. | 455,938 62.960% |
455,938![]() (New Position) |
Filing |